Ophthalmic Drugs
Date: | 28-Nov-17 to 29-Nov-17 |
Location: | Copthorne Tara Hotel / London / United Kingdom |
Category: | Healthcare & Pharmaceuticals Conferences & Trade Fairs |
SMi Group are delighted to introduce Ophthalmic Drugs which is being held on the 28th – 29th November 2017 at the Copthorne Tara Hotel in London, UK.
With the Ophthalmic Drugs market being worth over $37bn in 2026 (Vision Gain), Ophthalmic Drugs 2017 will enable you to explore novel approaches into treatments, new developments in medical devices, drug delivery and pre-clinical and clinical trials in order to deepen your understanding of inherited ocular diseases.
Here's a snap shot of our industry leading experts presenting this November:
- Naj Sharif, Executive Director in R&D, Head, Global Alliances & External Research, Santen Inc
- Mitchell de Long, Vice President, Chemistry, Aerie Pharmaceuticals
- Michael Lai, Global Program Medical Director, Novartis
- Sérgio Leal, Ophthalmologist Director, Global Clinical Leader, Bayer
- Victor Chong, Global Head of Ophthalmology, Boehringer Ingelheim
- Amir Shojaei, Vice President Therapeutic Area Head, Ophthalmology, Shire
- Tomas Navratil, Senior Vice President, Development, Envisia Therapeutics
Take a look at the full speaker line-up! www.ophthalmicdrugs.com/evvnt
- Some of the key topics addressed will involve:
- Novel approaches to the treatment of ocular diseases
- Advancements in ophthalmic clinical trials
- Combating challenges in drug release and delivery
- Animal models and regulatory considerations
- Commercial potential of ocular drugs and improved patient care
For those looking to attend there is currently a £300 early bird saving, for a limited time only.
Further information is available at: www.ophthalmicdrugs.com/evvnt
SMi is Proud to Present the Launch of…
Ophthalmic Drugs
Date: 28th – 29th November 2017
Location: London, UK
Website: www.ophthalmicdrugs.com/evvnt
Sponsors:
- EXPERIMENTICA
- LEICA MICROSYSTEMS
---end---
Contact Information:
For all media inquiries contact Pavan Solanki on Tel: +44 (0)20 7827 6048 / Email: psolanki@smi-online.co.uk
With the Ophthalmic Drugs market being worth over $37bn in 2026 (Vision Gain), Ophthalmic Drugs 2017 will enable you to explore novel approaches into treatments, new developments in medical devices, drug delivery and pre-clinical and clinical trials in order to deepen your understanding of inherited ocular diseases.
Here's a snap shot of our industry leading experts presenting this November:
- Naj Sharif, Executive Director in R&D, Head, Global Alliances & External Research, Santen Inc
- Mitchell de Long, Vice President, Chemistry, Aerie Pharmaceuticals
- Michael Lai, Global Program Medical Director, Novartis
- Sérgio Leal, Ophthalmologist Director, Global Clinical Leader, Bayer
- Victor Chong, Global Head of Ophthalmology, Boehringer Ingelheim
- Amir Shojaei, Vice President Therapeutic Area Head, Ophthalmology, Shire
- Tomas Navratil, Senior Vice President, Development, Envisia Therapeutics
Take a look at the full speaker line-up! www.ophthalmicdrugs.com/evvnt
- Some of the key topics addressed will involve:
- Novel approaches to the treatment of ocular diseases
- Advancements in ophthalmic clinical trials
- Combating challenges in drug release and delivery
- Animal models and regulatory considerations
- Commercial potential of ocular drugs and improved patient care
For those looking to attend there is currently a £300 early bird saving, for a limited time only.
Further information is available at: www.ophthalmicdrugs.com/evvnt
SMi is Proud to Present the Launch of…
Ophthalmic Drugs
Date: 28th – 29th November 2017
Location: London, UK
Website: www.ophthalmicdrugs.com/evvnt
Sponsors:
- EXPERIMENTICA
- LEICA MICROSYSTEMS
---end---
Contact Information:
For all media inquiries contact Pavan Solanki on Tel: +44 (0)20 7827 6048 / Email: psolanki@smi-online.co.uk
EIN News
provides powerful, real-time media monitoring, news aggregation & syndication services. Read the latest news about this topic. See:
- Autism News Today
- Brain Cancer News Today
- Breast Cancer News Today
- Breastfeeding News Today
- Conferences & Trade Shows Today
- Dental Industry Today
- Dietary Supplements News Today
- H1N1 News Today
- H7N9 Bird Flu News Today
- Health Insurance Exchanges News
- Healthcare Industry Today
- Healthcare Reform News Today
- Home Birth News Today
- Lung Cancer News Today
- MERS News Today
- Malaria News Today
- Marijuana News Today
- Mesothelioma News Today
- Pharmaceutical Industry Today
- Planned Parenthood News Today
- Prostate Cancer News Today
- SARS News Today
- Wellness News Today